Join to access to all OVN content. Join for Free

Results for 'pre-clinical'

Find oncology podcasts about pre-clinical — interviews, panel discussions, and expert-led audio on cancer innovation. Open any episode for listening options and show notes; switch tabs to explore articles, partners, and community members.

IO Clinical Trials During COVID-19
OVN Avatar Cancer Buzz Podcast
IO Clinical Trials During COVID-19

On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …

Jun 23rd • 13 mins listen

The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies

This podcast discusses whether the primary outcomes and study design for the reported trial were properly pre-specified and pre-registered prior to accruing participants.

Jan 24th • 12 mins listen

Address Knowledge Gaps in Evidence-Based Precision Medicine Care
OVN Avatar The Oncology Nursing Podcast
Address Knowledge Gaps in Evidence-Based Precision Medicine Care

ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN®, nurse practitioner for Community Hospital Oncology Physicians in Indianapolis, IN, and member of the Central Indiana ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss knowledge gaps in clinical practic…

Mar 29th • 40 mins listen

New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
OVN Avatar Asco Daily News Podcast
New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity

Drs. Shaalan Beg and Travis Osterman discuss a machine learning model, recently featured in JCO Clinical Cancer Informatics, that uses electronic health record data to accurately predict the effectiveness and toxicity of treatment with immune checkpoint inhibitors. The new AI model can be use…

Mar 21st • 16 mins listen

The Use of Biosimilars in Oncology
OVN Avatar ASCO Daily News Podcast
The Use of Biosimilars in Oncology

Host Dr. John Sweetenham, associate director of Clinical Affairs at the UT Southwestern Harold C. Simmons Comprehensive Cancer Center, and Dr. Zeina Nahleh, breast cancer medical oncologist and regional chair of the Cleveland Clinic Florida Cancer Institute, discuss the new ASCO Expert Panel …

Mar 24th • 18 mins listen

Recent Advances and Future Directions in Oncology
OVN Avatar Hematologic Oncology Update Podcast
Recent Advances and Future Directions in Oncology

Listen on Everand Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in acute myeloid leukemia, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung c…

Nov 23rd • 364 mins listen

Recent Advances and Real-World Implications in Chronic Lymphocytic Leukemia and Lymphomas
OVN Avatar Hematologic Oncology Update Podcast
Recent Advances and Real-World Implications in Chronic Lymphocytic Leukemia and Lymphomas

Listen on Everand Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas, multiple myeloma, genitourinary cancers, brea…

Mar 4th • 60 mins listen

Recent Advances and Real-World Implications in Multiple Myeloma
OVN Avatar Hematologic Oncology Update Podcast
Recent Advances and Real-World Implications in Multiple Myeloma

Listen on Everand Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas, multiple myeloma, genitourinary cancers,…

Mar 4th • 60 mins listen

New Guidelines for Managing Immunotherapy-Related Adverse Events
OVN Avatar The Oncology Nursing Podcast
New Guidelines for Managing Immunotherapy-Related Adverse Events

ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educati…

Feb 19th • 13 mins listen

 CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation
OVN Avatar The Oncology Nursing Podcast
CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation

“Just like with anything we do in oncology, a lot of education is required. Nurses and coordinators are critical to start the education and provide effective resources that are reinforced throughout the treatment,” ONS member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, F…

May 24th • 40 mins listen

Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care
OVN Avatar The Oncology Nursing Podcast
Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care

ONS members Kristin Daly, MSN, ANP-BC, AOCNP®, medical oncology nurse practitioner at the Siteman Cancer Center at the Washington University School of Medicine in St. Louis, MO, and Jessica Pforr, RN, AOCNP®, nurse practitioner at Mon Medical Center in Morgantown, WV, join Stephanie Jardine,…

Mar 29th • 38 mins listen

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…

Mar 30th • 47 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...